April 01 - 09:04
Exscientia will use AI to scan 15,000 drugs for COVID-19 treatment
A UK firm is working with the country's national science facility to scan drugs using AI. The aim is to learn of their potential effectiveness to treat COVID-19. Exscientia, based in Oxford, hopes to find a suitable drug that could be ready in the next six to 12 months. It expects to have a complete dataset inside eight weeks. Exscientia recently signed a $25 million AI research deal with Celgene.
> Tweets